Microbial engineering for the production of chemical and pharmaceutical products from the isoprenoid pathway
The invention relates to the production of one or more terpenoids through microbial engineering, and relates to the manufacture of products comprising terpenoids.
1. A method for making a product containing Myrcene or a derivative thereof, the method comprising:
providing an Escherichia coli ( E. coli ) that produces isopentyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) through an upstream methylerythritol pathway (MEP) and converts the IPP and DMAPP to Myrcene through a recombinantly expressed downstream synthesis pathway comprising Geranyl Diphosphate Synthase and Myrcene Synthase; and
culturing the E. coli to produce the Myrcene, wherein the accumulation of indole in the culture is controlled to below 100 mg/L to thereby increase Myrcene production; and optionally preparing a derivative of the Myrcene; and
incorporating the Myrcene or derivative into a fragrance product, a cosmetic product, oral care product, a pest control product, a cleaning product, a lubricant or surfactant, or a soap product.
2. The method of claim 1 , wherein accumulation of indole in the culture is controlled by balancing the upstream MEP pathway with the downstream synthesis pathway.
3. The method of claim 1 , further comprising, measuring the amount or concentration of indole continuously or intermittently.
4. The method of claim 1 , wherein accumulation of indole in the culture is maintained to below 50 mg/L.
5. The method of claim 1 , wherein accumulation of indole in the culture is maintained to below 10 mg/L.
6. The method of claim 1 , wherein the Myrcene is produced at 10 mg/L or more.
7. The method of claim 1 , wherein the Myrcene is produced at 100 mg/L or more.
8. The method of claim 1 , wherein the E. coli has additional copies of one or more of the dxs, idi, ispD and ispF genes of the MEP pathway.
9. A method for making a myrcene, the method comprising:
providing an Escherichia coli ( E. coli ) that produces isopentyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP) through an upstream methylerythritol pathway (MEP) and converts the IPP and DMAPP to myrcene through a recombinantly expressed downstream synthesis pathway comprising Geranyl Diphosphate Synthase and Myrcene Synthase; and
culturing the E. coli to produce the myrcene, wherein the accumulation of indole in the culture is controlled to below 100 mg/L to thereby increase terpenoid production; and
recovering the myrcene.